Breast cancer treatments more effective now than in the past

Breast cancer treatments more effective now than in the past
(HealthDay)—Comparison of recurrence and outcome patterns shows that current treatments for breast cancer are more effective than previous therapies, according to research published online Nov. 24 in the Journal of Clinical Oncology.

Rachel J.D. Cossetti, M.D., of the Vancouver Cancer Centre in Canada, and colleagues analyzed patterns of relapse for women with biopsy-proven stage I to stage III breast cancer who were diagnosed between 1986 and 1992 (cohort 1, or C1) or between mid-2004 and 2008 (cohort 2, or C2). Each cohort had 3,589 patients.

The researchers found the following distribution of breast cancer subtypes: estrogen-receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative, 70.8 percent; ER-negative/HER2-negative, 15.8 percent; ER-positive/HER2-positive, 6.9 percent; and ER-negative/HER2-positive, 6.6 percent. In the initial five intervals, differences in hazard rate of relapse (HRR) between the cohorts were greater for HER2-positive and ER-negative/HER2-negative . For all disease stages and grades, the HRR decreased in C2 compared with C1. The hazard rate of death also decreased for C2 versus C1 but to a lesser extent.

"Although current treatments are more effective, we still see late relapses in patients with ER-positive tumors and an early peak of recurrence in patients with ER-negative cancers," the authors write.


Explore further

Breast cancer recurrence defined by hormone receptor status

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Journal of Clinical Oncology

Copyright © 2014 HealthDay. All rights reserved.

Citation: Breast cancer treatments more effective now than in the past (2014, November 27) retrieved 25 June 2019 from https://medicalxpress.com/news/2014-11-breast-cancer-treatments-effective.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more